rituximab,ibrutinib,Bendamustine
biogen,roche,novartis,janssen,abbvie
['lymsm', 'improve']
addition of #ibrutinib to br in mcl #lymsm showing excellent improvement in pfs with modest cr benefits. toxicity as expected. good option for elderly patient who might be unable to tolerate more aggressive therapy. #asco22 
A hematologist @MoffittNews with interest in #lymsm. Tweets are not endorsements, and not medical advice.